← Open Payments lookup

DEVIN WENGERT: Open Payments

NPI 1346709557 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$781 in 39 payments from 9 companies in 2025. Trend: 2023 $703 · 2024 $1,309 · 2025 $781

Food & beverage: $754Education: $27
CompanyPaymentsAmount
Alkermes, Inc.10$186
Teva Pharmaceuticals USA, Inc.9$162
Otsuka America Pharmaceutical, Inc.5$101
E.R. Squibb & Sons, L.L.C.4$91
Janssen Pharmaceuticals, Inc3$83
Neurocrine BioSciences, Inc.3$65
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$48
ABBVIE INC.2$29
Vanda Pharmaceuticals Inc.1$16

Products named: ARISTADA, UZEDY, COBENFY, INVEGA SUSTENNA, INGREZZA, ABILIFY MAINTENA, CAPLYTA, AUSTEDO XR.

Industry payments across AZ — which companies pay providers there.